Annual Drug Patent Expirations for VYZULTA
Vyzulta is a drug marketed by Bausch And Lomb and is included in one NDA. It is available from one supplier. There are four patents protecting this drug.
This drug has fifty patent family members in thirty-eight countries.
The generic ingredient in VYZULTA is latanoprostene bunod. One supplier is listed for this compound. Additional details are available on the latanoprostene bunod profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
